Terminal deoxynucleotide transferase and preparation method therefor
By cleavage and flexible amino acid linker, a TdT mutant with diverse conformations is formed, which solves the problem of wild-type TdT conformation fixation, and achieves richer protein modification operations and better catalytic activity.
Patent Information
- Application Number
- PCT/CN2023/096407
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-17
- Filing Date
- 2023-05-25
- Publication Date
- 2024-11-21
AI Technical Summary
The C-terminal and N-terminal conformations of existing wild-type TdT are relatively fixed, which limits the selectivity and effect of protein modification operations and makes it difficult to achieve flexible enzymatic activity regulation.
By selecting the amino acid sites of the Loop region of TdT for cleavage, new N-terminal and C-terminal are generated, and then connecting with flexible amino acid linkers is used to form TdT mutants with diverse conformations, providing more choices for protein engineering operation.
It enriches the protein modification operation and effect of TdT, improves the flexibility and selectivity of enzyme activities, and obtains TdT mutants with novel C-terminal and N-terminals, showing better catalytic activity.
Smart Images

Figure CN2023096407_21112024_PF_FP_ABST
Abstract
Description
Terminal deoxynucleotidyl transferase and preparation method thereof Technical Field
[0001] The present invention relates to the field of genetic engineering, and in particular to a terminal deoxynucleotidyl transferase and a preparation method thereof. Background Art
[0002] Artificial DNA synthesis technology is an important foundation of modern genetic technology. Key methods for artificial DNA synthesis include: column-based chemical oligonucleotide synthesis, chip-based chemical oligonucleotide synthesis, oligonucleotide purification, oligonucleotide assembly, gene synthesis error correction and clone screening, large-fragment gene synthesis assembly, and the next generation of enzymatic DNA synthesis. Traditional methods for artificial DNA synthesis mostly rely on phosphoramidite chemistry to complete the reaction. In recent years, the third generation of artificial DNA synthesis based on enzymatic synthesis has gradually emerged as a promising method for artificial DNA synthesis. Among them, enzymatic synthesis technology based on terminal deoxynucleotidyl transferase (TdT) is a very promising DNA synthesis strategy.
[0003] A novel enzymatic nucleotide synthesis method utilizes the template-independent enzyme TdT for in vitro oligonucleotide fragment synthesis. TdT is a key tool for enzymatic oligonucleotide synthesis. Bollum first discovered TdT and proposed its use for single-stranded oligonucleotide synthesis. Subsequently, Schott and Schrade demonstrated that TdT exhibits minimal preference for four nucleotides and exhibits high coupling efficiency, enabling processive synthesis and extension of single-stranded DNA to produce homopolymers up to 8,000 nucleotides. To achieve controlled DNA synthesis catalyzed by TdT, TdT activity must be reversibly controlled. Keasling's team, in 2018, developed a mechanism for controlling TdT catalytic activity. This mechanism utilizes a reversible covalent bond between TdT and a single nucleotide to prevent further extension of the DNA chain synthesized by TdT. Breaking this reversible covalent bond allows the DNA chain to enter a new nucleotide addition cycle. This method achieves an average coupling efficiency of 97.7%, and a single cycle takes 2–3 minutes. DNA synthesis based on this innovative TdT has garnered widespread attention from both academia and industry.
[0004] Due to the increasing application of TdT in DNA synthesis, the significance of enzyme engineering for flexible regulation of TdT activity has become increasingly prominent. Novel TdT chimeras hold promise for enabling controlled enzymatic DNA synthesis. Designing additional enzyme activity-regulating functions for TdT (such as dimerization, conditional control of enzyme activity, and conformational control of the active site) often relies on adding additional functional groups or protein domains to the C- or N-terminus of TdT. The regulatory effects achieved by such functional groups or protein domains are highly dependent on the relative position of the C- or N-terminus (i.e., the point of addition of the additional functional groups) to the TdT active site or key domains. However, most existing TdTs are wild-type TdTs derived from natural sources (e.g., mouse, bovine, or bird). The conformations of the C- and N-termini of wild-type TdT, the distance between the C- or N-termini and the active site, and the ability of C- or N-terminal modifications to regulate the TdT active site are relatively fixed. This significantly limits the selectivity of potential subsequent protein engineering operations on TdT, restricting the protein modification operations and effects that can be achieved on TdT. Therefore, it is imperative to develop TdTs with diverse C- and N-terminal conformations.
[0005] Summary of the Invention
[0006] In view of the above-mentioned deficiencies in the prior art, the present invention aims to provide a TdT and a preparation method thereof, aiming to solve the problem that the C-terminus and N-terminus of the existing wild-type TdT have relatively fixed conformations, which greatly limits the protein modification operations and effects that can be achieved on TdT.
[0007] The technical solutions of the present invention are as follows:
[0008] A first aspect of the present invention provides a method for preparing TdT, comprising the steps of:
[0009] Providing wild-type TdT, which has an N-terminus and a C-terminus;
[0010] Selecting the amino acid site in the wild-type TdT Loop region as the cleavage site for cleavage to generate two amino acid sequences;
[0011] The two amino acid sequences are connected using a flexible amino acid linker, with one end of the flexible amino acid linker connected to the original N-terminus of the wild-type TdT and the other end connected to the original C-terminus of the wild-type TdT, to obtain a TdT mutant with new N-terminus and C-terminus.
[0012] Optionally, the amino acid sequence of the flexible amino acid linker is composed of 8-10 amino acid residues constructed by repeating the amino acid sequence shown in SEQ ID NO: 1.
[0013] Optionally, the amino acid sequence of the flexible amino acid linker is shown in SEQ ID NO: 2.
[0014] Optionally, the step of selecting an amino acid site in the wild-type TdT Loop region as a cleavage site for cleavage specifically includes:
[0015] After deleting the amino acids without catalytic function in the wild-type TdT, several loop regions in the three-dimensional structure of the wild-type TdT are determined, and amino acid sites are sequentially selected from the loop regions as cleavage sites for cleavage starting from the original N-terminus.
[0016] Optionally, the wild-type TdT is selected from one of wild-type TdT derived from mice, wild-type TdT derived from cattle, and wild-type TdT derived from birds.
[0017] Optionally, the wild-type TdT is selected from wild-type TdT of bird origin, and the amino acid sequence of the wild-type TdT of bird origin is shown in SEQ ID NO:3.
[0018] Optionally, the amino acids without catalytic function are amino acids 1-146.
[0019] Optionally, the amino acid site serving as the cleavage site in the wild-type TdT of avian origin is selected from one of the following amino acid sites:
[0020] 212G, 213L, 214P, 215C, 216V, 217G, 218D, 219Q, 220V, 221R, 350P, 351G, 352P, 353R, 354E, 355D, 356D, 357E, 358L, 359L.
[0021] The second aspect of the present invention provides a TdT mutant, which is prepared using the preparation method of the present invention as described above.
[0022] In a third aspect of the present invention, a TdT mutant is provided, wherein the amino acid sequence of the TdT mutant is shown in SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12 or SEQ ID NO:13.
[0023] Beneficial Effects: The present invention selects an amino acid site in the loop region of wild-type TdT as a cleavage site for cleavage, generating two amino acid sequences containing a new N-terminus and a new C-terminus, respectively. The two amino acid sequences are then linked using a flexible amino acid linker, with one end of the flexible amino acid linker connected to the original N-terminus of the wild-type TdT and the other end connected to the original C-terminus of the wild-type TdT, thereby obtaining a TdT mutant with a new N-terminus and C-terminus. By selecting different cleavage sites in the present invention, a series of different TdT mutants with new N-termini and C-termini can be obtained, providing a richer selection of C-termini and N-termini for TdT protein engineering, thereby enriching the protein modification operations and effects on TdT. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] FIG1 is a schematic diagram of the construction of the TdT mutant in Example 1 of the present invention.
[0025] FIG2 is a schematic diagram of the new N-terminal and C-terminal sites of the TdT mutant in Example 1 of the present invention.
[0026] FIG3 is an SDS-PAGE protein gel image of different TdT mutants in Example 2 of the present invention.
[0027] FIG4 is a denaturing urea PAGE protein gel image of the reactivity of different TdT mutants in Example 2 of the present invention.
[0028] FIG5 is a graph showing the enzyme catalytic rates of wt ZaTdT, cpTdT 0.1, and cpTdT 0.7 in Example 2 of the present invention. DETAILED DESCRIPTION
[0029] The present invention provides TdT and a method for preparing the same. To clarify the objectives, technical solutions, and effects of the present invention, the present invention is described in further detail below. It should be understood that the specific embodiments described herein are intended only to illustrate the present invention and are not intended to limit the present invention.
[0030] Unless otherwise defined, all technical terms and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in the specification of the present invention herein are only for the purpose of describing specific embodiments and are not intended to limit the present invention.
[0031] TdT is an important tool for enzymatic synthesis of oligonucleotides. However, most existing TdT is wild-type TdT from natural sources (e.g., mouse, bovine, or bird sources), with native C- and N-terminal conformations. However, the relatively fixed conformations of the native C- and N-termini significantly limit the selectivity of potential subsequent protein engineering operations on wild-type TdT, restricting the protein modification operations and effects that can be achieved on TdT. Based on this, an embodiment of the present invention provides a method for preparing a TdT mutant, comprising the following steps:
[0032] S1. providing a wild-type TdT having an N-terminus and a C-terminus;
[0033] S2, selecting an amino acid site in the wild-type TdT Loop region as a cleavage site to generate two amino acid sequences;
[0034] S3. Use a flexible amino acid linker to connect the two amino acid sequences, and connect one end of the flexible amino acid linker to the original N-terminus of the wild-type TdT, and the other end to the original C-terminus of the wild-type TdT, to obtain a TdT mutant with new N-terminus and C-terminus.
[0035] The present invention selects an amino acid site in the loop region of wild-type TdT as a cleavage site for cleavage, generating two amino acid sequences containing a new N-terminus and a new C-terminus, respectively (one amino acid sequence comprises the original C-terminus of wild-type TdT and the new N-terminus generated after cleavage, and the other amino acid sequence comprises the original N-terminus of wild-type TdT and the new C-terminus generated after cleavage). The two amino acid sequences are then connected using a flexible amino acid linker, with one end of the flexible amino acid linker connected to the original N-terminus of the wild-type TdT and the other end connected to the original C-terminus of the wild-type TdT, to obtain a TdT mutant with a new N-terminus and a new C-terminus. The present invention can select different cleavage sites and circularly permutate the primary structure of TdT protein using a circular permutation method to obtain a series of different TdT mutants with new N-termini and C-termini for further research, providing a wider range of C-terminal and N-terminal options for TdT protein engineering, thereby enriching the protein modification operations and effects on TdT.
[0036] In addition, with regard to catalytic activity alone, the catalytic activity of a series of TdT mutants with new N-termini and C-termini can be studied to screen out TdT mutants with catalytic activity (cpTdT mutants).
[0037] In this example, the amino acid sites in the loop region of TdT were selected as cleavage sites, rather than the amino acid sites in the a-helix and B-sheet secondary structure regions, to avoid damaging protein stability.
[0038] In some embodiments, the amino acid sequence of the flexible amino acid linker is composed of 8-10 amino acid residues constructed by repeating the amino acid sequence shown in SEQ ID NO: 1.
[0039] In some embodiments, the amino acid sequence of the flexible amino acid linker is as shown in SEQ ID NO: 2. In this embodiment, the C-terminus and N-terminus of the wild-type TdT are connected and fused using a flexible amino acid linker (such as the amino acid sequence shown in SEQ ID NO: 2, specifically GTGGSGGTGG) to form a complete TdT mutant with new C-terminus and N-terminus.
[0040] In some embodiments, the step of selecting an amino acid site in the wild-type TdT Loop region as a cleavage site for cleavage specifically comprises:
[0041] After deleting the amino acids without catalytic function in the wild-type TdT, several loop regions in the three-dimensional structure of the wild-type TdT are determined, and amino acid sites are sequentially selected from the loop regions as cleavage sites for cleavage starting from the original N-terminus.
[0042] In this embodiment, amino acids without catalytic function in wild-type TdT are deleted to avoid design redundancy. In this example, starting from the original N-terminus, amino acid sites are sequentially selected in several different loop regions as cleavage sites to obtain a series of cleavage sites, and then a series of different cyclically arranged TdT mutants with new N-termini and C-termini can be obtained.
[0043] When selecting a cleavage site in a certain loop region among several loop regions, you can try them one by one, for example, splitting every 1-3 amino acid sites.
[0044] In some embodiments, the wild-type TdT is selected from one of mouse-derived wild-type TdT, bovine-derived wild-type TdT, and bird-derived wild-type TdT, but is not limited thereto.
[0045] In some embodiments, the wild-type TdT is selected from wild-type TdT of avian origin, and the amino acid sequence of the wild-type TdT of avian origin is shown in SEQ ID NO:3.
[0046] In some embodiments, the amino acid sequence of the wild-type TdT of avian origin as shown in SEQ ID NO: 3 has amino acids 1-146 that do not have catalytic function.
[0047] In some embodiments, the amino acid site serving as the cleavage site in the wild-type TdT of avian origin is selected from one of the following amino acid sites:
[0048] 212G, 213L, 214P, 215C, 216V, 217G, 218D, 219Q, 220V, 221R, 350P, 351G, 352P, 353R, 354E, 355D, 356D, 357E, 358L, 359L. Based on the structural analysis of the loop region, it was confirmed that the positions corresponding to these amino acid residues are relatively flexible and are sites that can be rearranged.
[0049] The present invention also provides a TdT mutant, which is prepared using the preparation method described above in the present invention.
[0050] The present invention also provides a TdT mutant, wherein the amino acid sequence of the TdT mutant is shown in SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12 or SEQ ID NO: 13. Tests have found that the TdT mutants with amino acid sequences shown in SEQ ID NO: 5 and SEQ ID NO: 11 have better catalytic activity than wild-type TdT from avian origin (amino acid sequence shown in SEQ ID NO: 3), and the TdT mutants with amino acid sequences shown in SEQ ID NO: 6 and SEQ ID NO: 13 also have certain catalytic activity.
[0051] The following describes it in detail through specific examples.
[0052] Example 1 Preparation of TdT mutants
[0053] The method for preparing a TdT mutant comprises the following steps:
[0054] (1) As shown in FIG1 , based on the 3D structure and function analysis of wild-type avian TdT (wt ZaTdT, whose amino acid sequence is shown in SEQ ID NO: 3), amino acids 1-146 in the wt ZaTdT amino acid sequence, which have no substantial catalytic function, were deleted; then, the flexible loop region in the wt ZaTdT three-dimensional structure was determined;
[0055] (2) selecting an amino acid site in the selected loop region as the cleavage site, thereby generating two amino acid sequences with new N-termini and C-termini, respectively;
[0056] (3) A flexible amino acid linker (abbreviated as Linker, whose amino acid sequence is shown in SEQ ID NO: 2, specifically GTGGSGGTGG) was used to connect and fuse the original C-terminus and N-terminus of wt ZaTdT, and then the two amino acid sequences were connected to form a TdT mutant with a new C-terminus and N-terminus.
[0057] Repeat steps (2)-(3), starting from the original N-terminus, and sequentially select an amino acid site in the selected loop regions as a cleavage site, and finally obtain several TdT mutants, whose amino acid sequences are shown in SEQ ID NO:4-SEQ ID NO:13, respectively.
[0058] When the amino acid sequence of the TdT mutant is the sequence shown in SEQ ID NO: 5, the cleavage site selected in step (2) is 216V, and after cleavage, two amino acid sequences 147-216 and 217-513 are obtained (in the 147-216 amino acid sequence, the 147 side is the original N-terminus of TdT, and the 216 side is the newly generated C-terminus after cleavage; in the 217-513 amino acid sequence, the 217 side is the newly generated N-terminus after cleavage, and the 513 side is the original C-terminus of TdT). After the two amino acid sequences are connected by Linker, the TdT mutant with new N-terminus and C-terminus is obtained as 217-513-Linker-147-216 (as shown in FIG1 ), and a schematic diagram of the sites where the new N-terminus and C-terminus are located is shown in FIG2 ;
[0059] When the amino acid sequence of the TdT mutant is the sequence shown in SEQ ID NO: 11, the cleavage site selected in step (2) is 354E, and after cleavage, two amino acid sequences 147-354 and 355-513 are obtained (in the 147-354 amino acid sequence, the 147 side is the original N-terminus of TdT, and the 354 side is the newly generated C-terminus after cleavage; in the 355-513 amino acid sequence, the 355 side is the newly generated N-terminus after cleavage, and the 513 side is the original C-terminus of TdT). After the two amino acid sequences are connected by Linker, the TdT mutant with new N-terminus and C-terminus is obtained as 344-513-Linker-147-354 (as shown in FIG1 ), and a schematic diagram of the sites where the new N-terminus and C-terminus are located is shown in FIG2 ;
[0060] The design and arrangement of the amino acid sequences of other TdT mutants were similar.
[0061] Example 2 Screening of cpTdT mutants
[0062] A circular permutation TdT mutant gene was constructed by homologous recombination. After correct sequencing, the gene was transformed into the Escherichia coli expression strain BL21(DE3) using the heat shock method for expression and purification of the TdT mutant. The expression level and purity of the TdT mutant were determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). After purification, the catalytic activity of different TdT mutants was tested using denaturing urea polyacrylamide gel electrophoresis. The most suitable cpTdT mutant as a template for transformation was selected based on the expression level, purity, and catalytic activity of the TdT mutant. The specific steps are as follows:
[0063] The expression of TdT mutant was purified by heat shock method into E. coli expression strain BL21 (DE3):
[0064] 1 μL of correctly sequenced plasmid was added to E. coli BL21 (DE3) competent cells. After incubation on ice for 30 minutes, the cells were heat-shocked in a 42°C water bath for 45 seconds and immediately removed and placed on ice for 5 minutes. 500 μL of BL medium was added and the cells were incubated at 190 rpm in a 37°C incubator for 50 minutes. The cells were centrifuged at 10,000 rpm for 1 minute. The precipitated cells were evenly spread on a culture dish and placed in an incubator overnight. Single colonies were picked the next day.
[0065] A single clone mutant was selected and incubated in 200 mL of LB medium containing 100 μg / mL kanamycin for 3 hours until the OD600 value was 0.6; IPTG (isopropyl-β-d-thiogalactose) was added to a final concentration of 0.5 mM, and the cells were induced at 230 rpm at 16°C overnight; the cells were collected by centrifugation at 6000 g for 10 min and then resuspended in 50 mL of lysis buffer (30 mM Tris-HCl buffer, 500 mM NaCl, 20 mM imidazole); the cells were lysed using a high-pressure homogenizer, centrifuged at 6000 g for 10 min at 4°C to remove cell debris, and the clarified lysate was passed through a nickel affinity chromatography column under gravity; non-target proteins were removed with 50 mL of wash buffer (30 mM Tris-HCl buffer, 200 mM NaCl, 40 mM imidazole), and then washed with 5 mL of elution buffer (30 mM Tris-HCl buffer, 200 mM The target protein was collected by adding 2% NaCl, 200 mM imidazole, and the eluted protein was concentrated and dialyzed using a 30 kDa molecular weight ultrafiltration centrifugal column to obtain the purified circularly arranged TdT mutant.
[0066] TdT mutant concentration and expression level test (sodium dodecyl sulfate polyacrylamide gel electrophoresis, abbreviated as SDS-PAGE):
[0067] Mix 5 μL of TdT mutant sample with 20 μL of 5X loading buffer and heat at 70°C for 5 minutes to obtain the sample to be tested; prepare 8 mL of 10% separation gel and 5 mL of 10% stacking gel, pour the separation gel between the glass plates of the gel rack, wait for it to solidify, pour the stacking gel and insert the sample comb, install the electrophoresis system, add SDS electrophoresis buffer, remove the sample comb, add the marker and the sample to be tested to the sample well, and perform electrophoresis at a constant voltage of 200 V for 60 minutes; remove the gel and stain it with Coomassie Brilliant Blue solution for 30 minutes, then decolorize it overnight and image it, using wt ZaTdT as a control.
[0068] Activity test (denatured urea polyacrylamide gel electrophoresis, abbreviated as denatured urea PAGE):
[0069] Add oligonucleotide primers, deoxyribonucleotides, and CoCl2 to HEPES buffer to prepare a reaction solution containing 1 μM oligonucleotide primers, 0.1 mM deoxyribonucleotides, and 0.25 mM CoCl2, and store in a 30°C metal bath until use;
[0070] Take 1 μL of 0.5 mg / mL TdT mutant sample and add it to 20 μL of reaction preparation solution. After mixing evenly with a pipette, react at 37°C for 30 minutes, and then heat at 95°C for 15 seconds to stop the reaction. Take 5 μL of reaction solution and mix with 5 μL of 2X loading buffer to obtain the test sample. Prepare 10 mL of 15% urea denaturing gel and pour it between the glass plates of the gel rack. Insert the sample comb and assemble the electrophoresis system. Add TBE running buffer, remove the sample comb, and add the marker and test sample to the sample well. Perform electrophoresis at a constant voltage of 200 V for 60 minutes. Observe the results on a gel imager. Oligonucleotide primers and wt ZaTdT are used as controls for this activity test.
[0071] Here are the results:
[0072] The SDS-PAGE protein gel image of the TdT mutants with amino acid sequences of SEQ ID NO:4 to SEQ ID NO:13 is shown in Figure 3 (the TdT mutants with amino acid sequences of SEQ ID NO:4 to SEQ ID NO:13 correspond to cpTdT-0.0, cpTdT-0.1, cpTdT-0.2, cpTdT-0.3, cpTdT-0.4, cpTdT-0.5, cpTdT-0.6, cpTdT-0.7, cpTdT-0.8, and cpTdT-0.9 in the figure, respectively). As can be seen from Figure 3, the TdT mutants with amino acid sequences of SEQ ID NO:5 and SEQ ID NO:11 (i.e., cpTdT-0.1 and cpTdT-0.7) have significant protein expression in the E. coli expression system.
[0073] The denaturing urea PAGE protein gel image after the reaction of TdT mutants with amino acid sequences of SEQ ID NO:4-SEQ ID NO:13 is shown in Figure 4. As can be seen from Figure 4, the TdT mutants with amino acid sequences of SEQ ID NO:5 and SEQ ID NO:11 (i.e., cpTdT-0.1 and cpTdT-0.7) have the best catalytic activity.
[0074] The catalytic rate results of the TdT mutants with amino acid sequences of SEQ ID NO: 5 and SEQ ID NO: 11 are shown in Figure 5. As can be seen from Figure 5, the TdT mutants with amino acid sequences of SEQ ID NO: 4 and SEQ ID NO: 5 (i.e., cpTdT-0.1 and cpTdT-0.7) did not cause obvious changes in enzyme catalytic activity and had better catalytic activity than wtZaTdT.
[0075] In summary, the embodiment of the present invention obtains a protein library of circularly arranged TdT through the steps of protein design, plasmid construction, recombinant expression of TdT mutants in Escherichia coli, purification of TdT mutants, etc. Subsequently, TdT with catalytic activity and novel C-terminus and N-terminus was determined by testing the enzyme activity of TdT mutants. In general, the present invention circularly arranges the primary structure of the protein of wild-type TdT, selects suitable protein domains to open up new C-terminus and N-terminus, and uses a specific flexible amino acid linker to connect the original C-terminus and N-terminus of wild-type TdT to obtain a series of TdT mutants with novel C-terminus and N-terminus, providing a richer selection of C-terminus and N-terminus for protein engineering of TdT. In addition, the present invention further optimizes the flexible amino acid linker and the original C-terminus or N-terminus, and screens and obtains TdT mutants with novel C-terminus and N-terminus and higher catalytic activity from a series of TdT mutants with novel C-terminus and N-terminus.
[0076] It should be understood that the application of the present invention is not limited to the above examples. For those skilled in the art, improvements or changes can be made based on the above description. All these improvements and changes should fall within the scope of protection of the claims attached to the present invention.
Claims
1. A method for preparing a terminal deoxynucleotidyl transferase mutant, characterized in that: Includes steps: Providing a wild-type terminal deoxynucleotidyl transferase having an N-terminus and a C-terminus; Selecting the amino acid site in the loop region of the wild-type terminal deoxynucleotidyl transferase as the cleavage site for cleavage to generate two amino acid sequences; The two amino acid sequences are connected by using a flexible amino acid linker, and one end of the flexible amino acid linker is connected to the original N-terminus of the wild-type terminal deoxynucleotidyl transferase, and the other end is connected to the original C-terminus of the wild-type terminal deoxynucleotidyl transferase, so as to obtain a terminal deoxynucleotidyl transferase mutant with a new N-terminus and C-terminus.
2. The preparation method according to claim 1, characterized in that: The amino acid sequence of the flexible amino acid linker is composed of 8-10 amino acid residues constructed by repeating the amino acid sequence shown in SEQ ID NO:
1.
3. The preparation method according to claim 2, characterized in that: The amino acid sequence of the flexible amino acid linker is shown in SEQ ID NO:
2.
4. The preparation method according to claim 1, characterized in that: The step of selecting the amino acid site in the loop region of the wild-type terminal deoxynucleotidyl transferase as the cleavage site for cleavage specifically comprises: After deleting the amino acids without catalytic function in the wild-type terminal deoxynucleotidyl transferase, several loop regions in the three-dimensional structure of the wild-type terminal deoxynucleotidyl transferase are determined, and amino acid sites are selected in turn from the original N-terminus in several loop regions as cleavage sites for cleavage.
5. The preparation method according to claim 4, characterized in that: The wild-type terminal deoxynucleotidyl transferase is selected from one of the wild-type terminal deoxynucleotidyl transferase from mice, the wild-type terminal deoxynucleotidyl transferase from cattle, and the wild-type terminal deoxynucleotidyl transferase from birds.
6. The preparation method according to claim 5, characterized in that: The wild-type terminal deoxynucleotidyl transferase is selected from a wild-type terminal deoxynucleotidyl transferase derived from a bird, and the amino acid sequence of the wild-type terminal deoxynucleotidyl transferase derived from a bird is shown in SEQ ID NO:
3.
7. The preparation method according to claim 6, characterized in that: The amino acids without catalytic function are amino acids 1-146.
8. The preparation method according to claim 6, characterized in that: The amino acid site used as the cleavage site in the wild-type terminal deoxynucleotidyl transferase of bird origin is selected from one of the following amino acid sites: 212G, 213L, 214P, 215C, 216V, 217G, 218D, 219Q, 220V, 221R, 350P, 351G, 352P, 353R, 354E, 355D, 356D, 357E, 358L, 359L.
9. A terminal deoxynucleotidyl transferase mutant, characterized in that The preparation method is described in any one of claims 1 to 8.
10. A terminal deoxynucleotidyl transferase mutant, characterized in that The amino acid sequence of the terminal deoxynucleotidyl transferase mutant is shown in SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12 or SEQ ID NO:13.
Citation Information
Patent Citations
New function and application of nucleoside transferase
CN112746063A
MODIFIED TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TdT) ENZYMES
CN113454212A
Terminal deoxynucleotidyl transferase mutant, coding gene thereof, recombinant expression plasmid and genetically engineered bacterium
CN114921436A
Generation of nucleic acids with modified bases using recombinant terminal deoxynucleotide transferases
CN115916967A
Thermally stable terminal deoxynucleotide transferases
CN116096872A
